Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
White Matter | 5 | 2022 | 174 | 2.320 |
Why?
|
Cognition Disorders | 6 | 2023 | 342 | 1.880 |
Why?
|
Cognitive Dysfunction | 6 | 2023 | 176 | 1.730 |
Why?
|
Alzheimer Disease | 5 | 2023 | 565 | 1.680 |
Why?
|
Neuropsychological Tests | 12 | 2021 | 517 | 1.420 |
Why?
|
Cognition | 9 | 2021 | 513 | 1.310 |
Why?
|
Aging | 8 | 2020 | 911 | 1.260 |
Why?
|
Diffusion Tensor Imaging | 6 | 2022 | 211 | 1.110 |
Why?
|
Memory, Episodic | 1 | 2023 | 10 | 0.860 |
Why?
|
Marijuana Smoking | 2 | 2021 | 108 | 0.820 |
Why?
|
Neuropsychology | 3 | 2018 | 11 | 0.770 |
Why?
|
Brain | 7 | 2023 | 2176 | 0.760 |
Why?
|
Cognitive Reserve | 1 | 2020 | 6 | 0.720 |
Why?
|
Leukoaraiosis | 1 | 2020 | 14 | 0.720 |
Why?
|
Marijuana Use | 1 | 2020 | 35 | 0.680 |
Why?
|
Psychometrics | 4 | 2019 | 514 | 0.670 |
Why?
|
Aged | 21 | 2023 | 14862 | 0.630 |
Why?
|
Aged, 80 and over | 15 | 2023 | 4848 | 0.620 |
Why?
|
Myelin Sheath | 2 | 2018 | 115 | 0.590 |
Why?
|
Marijuana Abuse | 1 | 2020 | 251 | 0.560 |
Why?
|
Depression | 2 | 2012 | 943 | 0.470 |
Why?
|
Geriatric Assessment | 3 | 2015 | 107 | 0.470 |
Why?
|
Neuroimaging | 2 | 2013 | 122 | 0.440 |
Why?
|
Humans | 31 | 2023 | 68618 | 0.380 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2022 | 689 | 0.370 |
Why?
|
Sleep Wake Disorders | 1 | 2012 | 94 | 0.370 |
Why?
|
Substance-Related Disorders | 1 | 2020 | 1242 | 0.370 |
Why?
|
Middle Aged | 12 | 2023 | 21147 | 0.360 |
Why?
|
Troponin | 1 | 2009 | 25 | 0.350 |
Why?
|
Sleep | 1 | 2012 | 263 | 0.340 |
Why?
|
S100 Proteins | 1 | 2009 | 42 | 0.340 |
Why?
|
Nerve Growth Factors | 1 | 2009 | 75 | 0.340 |
Why?
|
Anxiety | 1 | 2012 | 422 | 0.320 |
Why?
|
Female | 23 | 2021 | 38074 | 0.310 |
Why?
|
Women | 2 | 2018 | 40 | 0.300 |
Why?
|
Male | 22 | 2020 | 37321 | 0.280 |
Why?
|
Leadership | 2 | 2018 | 136 | 0.270 |
Why?
|
Depressive Disorder | 1 | 2009 | 621 | 0.260 |
Why?
|
Cardiovascular Diseases | 4 | 2014 | 940 | 0.240 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2013 | 49 | 0.220 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2022 | 239 | 0.220 |
Why?
|
Access to Information | 1 | 2023 | 21 | 0.210 |
Why?
|
Cohort Studies | 4 | 2022 | 2358 | 0.210 |
Why?
|
Psychiatric Status Rating Scales | 3 | 2017 | 782 | 0.200 |
Why?
|
Executive Function | 5 | 2015 | 106 | 0.200 |
Why?
|
Biomarkers | 2 | 2022 | 1593 | 0.190 |
Why?
|
Saliva | 1 | 2021 | 142 | 0.190 |
Why?
|
Gait Disorders, Neurologic | 1 | 2022 | 86 | 0.180 |
Why?
|
Olfaction Disorders | 1 | 2022 | 100 | 0.180 |
Why?
|
Alleles | 2 | 2013 | 386 | 0.180 |
Why?
|
Bacteria | 1 | 2021 | 193 | 0.180 |
Why?
|
Amyloid beta-Peptides | 1 | 2021 | 191 | 0.180 |
Why?
|
Heart Diseases | 1 | 2022 | 276 | 0.170 |
Why?
|
Reproducibility of Results | 4 | 2019 | 2077 | 0.170 |
Why?
|
Memory | 4 | 2015 | 214 | 0.170 |
Why?
|
Parkinson Disease | 1 | 2022 | 272 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 2223 | 0.160 |
Why?
|
Self Report | 1 | 2020 | 371 | 0.150 |
Why?
|
Macrophages | 1 | 2021 | 647 | 0.150 |
Why?
|
Models, Neurological | 1 | 2018 | 136 | 0.150 |
Why?
|
Axons | 1 | 2018 | 139 | 0.140 |
Why?
|
Dementia | 2 | 2017 | 158 | 0.140 |
Why?
|
Cholesterol | 2 | 2017 | 331 | 0.140 |
Why?
|
Neural Pathways | 1 | 2018 | 324 | 0.140 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 33 | 0.130 |
Why?
|
Adult | 7 | 2020 | 21403 | 0.130 |
Why?
|
Reading | 1 | 2014 | 19 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2015 | 1054 | 0.120 |
Why?
|
Writing | 1 | 2014 | 29 | 0.110 |
Why?
|
Statistics as Topic | 2 | 2012 | 219 | 0.110 |
Why?
|
Semantics | 1 | 2013 | 37 | 0.110 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 2279 | 0.110 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2013 | 627 | 0.110 |
Why?
|
Attention | 2 | 2012 | 225 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2013 | 123 | 0.110 |
Why?
|
Mental Health | 1 | 2015 | 278 | 0.110 |
Why?
|
Schools | 1 | 2014 | 156 | 0.110 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2012 | 6 | 0.100 |
Why?
|
Surveys and Questionnaires | 2 | 2012 | 2800 | 0.100 |
Why?
|
Minority Groups | 1 | 2014 | 197 | 0.100 |
Why?
|
Models, Statistical | 1 | 2016 | 448 | 0.100 |
Why?
|
Dementia, Vascular | 1 | 2012 | 22 | 0.100 |
Why?
|
Data Collection | 1 | 2013 | 420 | 0.100 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2013 | 138 | 0.100 |
Why?
|
Personality Inventory | 1 | 2012 | 197 | 0.100 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2013 | 237 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2013 | 1040 | 0.090 |
Why?
|
Ghrelin | 1 | 2010 | 8 | 0.090 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 301 | 0.090 |
Why?
|
Neurologic Examination | 1 | 2011 | 107 | 0.090 |
Why?
|
Malingering | 1 | 2011 | 36 | 0.090 |
Why?
|
Hospitals, Veterans | 1 | 2011 | 147 | 0.090 |
Why?
|
S100 Calcium Binding Protein beta Subunit | 1 | 2009 | 15 | 0.090 |
Why?
|
P-Selectin | 1 | 2009 | 16 | 0.080 |
Why?
|
Disease Progression | 3 | 2020 | 1038 | 0.080 |
Why?
|
Retrospective Studies | 1 | 2021 | 7277 | 0.080 |
Why?
|
Proteins | 1 | 2013 | 474 | 0.080 |
Why?
|
Motor Activity | 2 | 2009 | 621 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2015 | 1085 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2021 | 1553 | 0.080 |
Why?
|
Multivariate Analysis | 1 | 2011 | 1046 | 0.080 |
Why?
|
Gender Identity | 2 | 2018 | 47 | 0.080 |
Why?
|
Algorithms | 1 | 2013 | 1196 | 0.070 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2008 | 124 | 0.070 |
Why?
|
Obesity | 1 | 2013 | 1076 | 0.060 |
Why?
|
Comorbidity | 3 | 2015 | 1426 | 0.060 |
Why?
|
New York City | 2 | 2014 | 49 | 0.060 |
Why?
|
Veterans | 1 | 2011 | 904 | 0.050 |
Why?
|
Anisotropy | 1 | 2022 | 105 | 0.050 |
Why?
|
Dihydroxyphenylalanine | 1 | 2022 | 13 | 0.050 |
Why?
|
Cluster Analysis | 1 | 2022 | 219 | 0.050 |
Why?
|
DNA, Ribosomal | 1 | 2021 | 59 | 0.050 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2021 | 85 | 0.050 |
Why?
|
Globus Pallidus | 1 | 2022 | 64 | 0.050 |
Why?
|
United States | 1 | 2013 | 7367 | 0.050 |
Why?
|
Smell | 1 | 2022 | 131 | 0.050 |
Why?
|
DNA, Bacterial | 1 | 2021 | 150 | 0.050 |
Why?
|
Psychomotor Performance | 2 | 2013 | 213 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 208 | 0.050 |
Why?
|
Phylogeny | 1 | 2021 | 197 | 0.050 |
Why?
|
Young Adult | 1 | 2012 | 5717 | 0.050 |
Why?
|
Mental Status Schedule | 2 | 2012 | 31 | 0.050 |
Why?
|
Gait | 1 | 2022 | 120 | 0.050 |
Why?
|
Age Factors | 2 | 2017 | 1864 | 0.040 |
Why?
|
Dopamine | 1 | 2022 | 474 | 0.040 |
Why?
|
Phenotype | 1 | 2022 | 947 | 0.040 |
Why?
|
Adolescent | 1 | 2012 | 8912 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2020 | 307 | 0.040 |
Why?
|
Societies | 1 | 2018 | 15 | 0.040 |
Why?
|
Organizations | 1 | 2018 | 16 | 0.040 |
Why?
|
Psychology | 1 | 2018 | 36 | 0.040 |
Why?
|
Editorial Policies | 1 | 2018 | 32 | 0.040 |
Why?
|
Cell Line | 1 | 2021 | 1752 | 0.040 |
Why?
|
History, 21st Century | 1 | 2018 | 127 | 0.040 |
Why?
|
Certification | 1 | 2018 | 66 | 0.040 |
Why?
|
History, 20th Century | 1 | 2018 | 248 | 0.040 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 127 | 0.040 |
Why?
|
Forecasting | 1 | 2018 | 277 | 0.030 |
Why?
|
Research | 1 | 2018 | 214 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2017 | 92 | 0.030 |
Why?
|
Hypolipidemic Agents | 1 | 2017 | 82 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 442 | 0.030 |
Why?
|
Language Tests | 1 | 2015 | 36 | 0.030 |
Why?
|
Internet | 1 | 2018 | 390 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2017 | 252 | 0.030 |
Why?
|
Risk Factors | 2 | 2015 | 5731 | 0.030 |
Why?
|
Language | 1 | 2015 | 120 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2021 | 2550 | 0.030 |
Why?
|
Quality of Life | 1 | 2022 | 1515 | 0.030 |
Why?
|
Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 1 | 2013 | 4 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 1465 | 0.030 |
Why?
|
Genetic Association Studies | 1 | 2013 | 103 | 0.030 |
Why?
|
Image Enhancement | 1 | 2013 | 143 | 0.030 |
Why?
|
Genetic Carrier Screening | 1 | 2012 | 25 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2017 | 445 | 0.030 |
Why?
|
Reaction Time | 1 | 2012 | 170 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2014 | 326 | 0.020 |
Why?
|
Sex Factors | 1 | 2014 | 1266 | 0.020 |
Why?
|
Mice | 1 | 2021 | 8474 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 786 | 0.020 |
Why?
|
Body Mass Index | 1 | 2013 | 867 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 1753 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2009 | 180 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2009 | 218 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2013 | 1851 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2013 | 3259 | 0.020 |
Why?
|
Animals | 1 | 2021 | 20881 | 0.010 |
Why?
|